SEGMENT INFORMATION

12 Months Ended

Dec. 31, 2011

SEGMENT INFORMATION [Abstract]

SEGMENT INFORMATION

NOTE 12 - SEGMENT INFORMATION

The Company's reportable segments are strategic businesses that offer products and services to different markets. The Company presently has three segments: Specialty Products; Food, Pharma & Nutrition; and Animal Nutrition & Health. The Specialty Products segment provides specialty-packaged chemicals for use in healthcare and other industries. Human choline nutrient products, pharmaceutical products and encapsulated products are reported in the Food, Pharma & Nutrition segment. This segment provides microencapsulation solutions to a variety of applications in food, pharmaceutical and nutritional ingredients to enhance performance of nutritional fortification, processing, mixing, packaging applications and shelf-life. The Animal Nutrition & Health segment is in the business of manufacturing and supplying choline chloride, an essential nutrient for animal health, to the poultry and swine industries. In addition, certain derivatives of choline chloride are also manufactured and sold into industrial applications and are included in this segment. Chelated minerals and specialty nutritional products for the animal health industry are also reported in this segment. The Company sells products for all segments through its own sales force, independent distributors, and sales agents. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.

Business Segment Net Sales:

	2011		2010		2009
Specialty Products	$	47,851	$	42,239	$	36,368
Food, Pharma & Nutrition		42,525		41,994		35,407
Animal Nutrition & Health		201,491		170,838		147,663
Total	$	291,867	$	255,071	$	219,438

Business Segment Earnings Before Income Taxes:

	2011		2010		2009
Specialty Products	$	18,636	$	15,944	$	14,250
Food, Pharma & Nutrition		11,113		9,748		5,029
Animal Nutrition & Health		26,476		24,078		21,380
Interest and other income (expense)		513		361		(57	)
Total	$	56,738	$	50,131	$	40,602

Depreciation/Amortization:

	2011		2010		2009
Specialty Products	$	1,291	$	1,071	$	826
Food, Pharma & Nutrition		1,486		1,551		1,489
Animal Nutrition & Health		6,514		5,937		5,815
Total	$	9,291	$	8,559	$	8,130

Business Segment Assets:

	2011		2010		2009
Specialty Products	$	25,618	$	25,113	$	19,235
Food, Pharma & Nutrition		17,319		17,930		19,044
Animal Nutrition & Health		108,410		106,667		101,896
Other Unallocated		120,370		78,914		47,638
Total	$	271,717	$	228,624	$	187,813

Other unallocated assets consist of certain cash, receivables, prepaid expenses, equipment and leasehold improvements, net of accumulated depreciation, and deferred income taxes, which the Company does not allocate to its individual business segments.

Capital Expenditures:

	2011		2010		2009
Specialty Products	$	1,034	$	334	$	286
Food, Pharma & Nutrition		403		1,390		639
Animal Nutrition & Health		5,175		5,833		2,504
Total	$	6,612	$	7,557	$	3,429

Geographic Revenue Information:

	2011		2010		2009
United States	$	191,204	$	170,949	$	145,226
Foreign Countries		100,663		84,122		74,212
Total	$	291,867	$	255,071	$	219,438

Geographic Area Data – Long-Lived Assets (excluding intangible assets):

	2011		2010		2009
United States	$	33,511	$	32,754	$	31,233
Italy		10,771		10,634		10,346
Total	$	44,282	$	43,388	$	41,579